Engineering Human 3D Cardiac Tissues for Predictive Functional Drug Screening.

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Drug Discovery

Background:

• Cardiotoxicity is a major reason for drug withdrawal.
• Current preclinical models (2D cultures, animal studies) have limitations in predicting human cardiac responses.
• There is a need for human-relevant in vitro platforms for cardiotoxicity assessment.

Purpose of the Study:

• To develop a high-throughput, human-relevant in vitro platform for predictive cardiotoxicity screening.
• To utilize 3D cardiac tissues derived from human induced pluripotent stem cells (hiPSCs).
• To enable functional assessment of drug effects on cardiac tissue.

Main Methods:

• Engineered 3D cardiac tissues from hiPSCs within a thermoresponsive hydrogel.
• Validated tissue maturation using immunostaining and calcium imaging.
• Quantified contractile performance (beat rate, contraction amplitude) via video analysis.
• Tested dose-dependent effects of various cardioactive compounds.

Main Results:

• The engineered cardiac tissues demonstrated functional maturation and stable contractile behavior.
• Drug testing revealed compound-specific, dose-dependent functional responses.
• The platform accurately reproduced expected physiological responses for tested compounds.

Conclusions:

• The developed scalable platform offers sensitive, multiparametric functional assessment of cardiac tissues.
• This cost-effective tool enhances preclinical drug safety testing and translational accuracy.
• The platform reduces reliance on animal models for cardiotoxicity evaluation.